Escudero E, Vinue L ,Teshager T, Torres C, Moreno MA. Resistance mechanisms and farm-level distribution of fecal Escherichia coli isolates resistant to extended-spectrum cephalosporins in pigs in Spain. Res Vet Sci 2010;88(1):83-7.
2-Falagas ME, Karageorgopoulos DE. Extended-spectrum beta-lactamase-producing organisms. J Hospe Infect 2009;73(4):345-54.
3-Jacoby GA, Munoz-Price LS. Mechanisms of disease: the new β-Lactamases. N Engl J Med 2005;352:380-91.
4-Rawat D, Nair D. Extended-spectrum β-lactamase in Gram Negative Bacteria. J Glob Infect Dis 2010;2(3):263-74. .
5-Al-Agamy MH, Shibl AM, Tawfik AF. Prevalence and molecular characterization of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Ann Saudi Med 2009;29(4):253-7.
6-Mohamudha PR, Srinivas AN, Rahul D, Harish BN, Parija SC. Molecular epidemiology of multidrug resistant Extended-Spectrum β-Lactamase producing Klebsiella pneumoniae outbreak in a neonatal intensive care unit. Int J Collaborative Res Internal Med Public Health 2010;2(7):226-38.
7-Munier GK, Johnson CL, Snyder JW, Moland ES, Hanson ND, Thomson KS. Positive extended-spectrum-beta-lactamase (ESBL) screening results may be due to AmpC beta-lactamases more often than to ESBLs. J Clin Microbiol 2010;48(2):673-4.
8-Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2005;14(4):933-51.
9-Al-Zarouni M, Senok A, Rashid F, Al-Jesmi SM, Panigrahi D. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Med Princ Pract 2008;17(1):32-6.
10-Performance standard for antimicrobial susceptibility testing, 20th informational supplement. Clin Laboratory Standard Institue 2010;30(1):40-52.
11-Forbes BA, Sahm DF, Weissfeld AS. Baily & Scott's diagostic microbiology. 12th ed. Missouri: Mosby Elsevier; 2007. P. 525-32.
12-Clinical and Laboratory Standards Institute. Performans Standards for Antimicrobial Susceptibility Testing:Informational Supplement M100-S18. Philadelphia: CLSI; 2008.
13-Quinteros M, Radice M, Gardella N, Rodriguez MM, Costa N, Korbenfeld D, et al. Extended-spectrum ß-Lactamases in Enterobacteriaceae in Buenos Aires, Argentina, Public Hospitals. Antimicrob Agents Chemother 2003;47(9):2864-7.
14-Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995;8(4):557-84.
15-Nijssen S, Florijn A, Bonten MJM, Schmitz FJ, Verhoef J, Fluit AC. Beta- lactam susceptibilities and prevalence of ESBL-producing isolates amonge more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents 2004;24:585-90.
16-Jones RN, Biedenbach DJ, Gales AC. Sustained activity and spectrum of selected extended-spectrum beta-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: report from the SENTRY antimicrobial surveillance program (USA, 1997-2000). Int J Antimicrob Agents 2003;21(1):1-7.
17-Moosavian M, Deiham B. Distribution of TEM, SHV and CTX-M Genes among ESBL-producing Enterobacteriaceae isolates in Iran. Afr J Microbiol Res 2012;6(26):5433-9.
18-Nasehi L, Shahcheraghi F, Sadat NV, Nematzadeh SH. PER,CTX-M,TEM and SHV Beta-lactamases in clinical isolates of Klebsiella pneumoniae isolated from Tehran. Iran J Basic Med Sci 2010;13(3):111-18. [In Persian]
19-Pages JM, Lavigne JP, Leflon-Guibout V, Marcon E, Bert F, Noussair L, et al. Efflux pump, the masked side of beta-Lactam resistance inKlebsiella pneumoniaeclinical isolates. PLoS One 2009;4(3):e4817.
20-Ananthan S, Subha A. Cefoxitin resistance mediated by loss of a porin in clinical strains of Klebsiella pneumoniaeand Escherichia coli. Indian J Med Microbiol 2005;23(1):20-3.
21-Goossens H. MYSTIC program: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis 2001;41(4):183-9.
22-Torshizi R, Zamanzad B, Mokhatarian K, Karimi A. Survey of Beta-lactamase gene of CTXM in Extended Spectrum Beta-lactamase producing Enterobacteriaceae from clinical isolates in hospitalized patients in Shahrekord. Shahrekord Univ Med J 2011;13(3):9-17.
23-Feizabadi MM, Mohammadi-Yeganeh S, Mirsalehian A, MirAfshar SM, Mahboobi M, Nili F, et al. Genetic characterization of ESBL producing strains of Klebsiella from Tehran hospitals. J Infect Dev Ctries 2010;4(10):609-15.
24-MirSalehian A, Akbari Nakhjavani F, Peymani A, Kazami B, Jabal Ameli F, MirAfshar SM. Prevalence of extended spectrum β-lactamases– Producing Enterobacteriaceae by phenotypic and genotypic methods in intensive care units in Tehran, Iran. Daru 2008;16(3):169-73.